Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript
Director departure
Appointed director

VOLITIONRX LTD (VNRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/30/2023 8-K Appointed a new director
Docs: "2015 Stock Incentive Plan, as amended"
06/14/2022 8-K Quarterly results
06/22/2021 8-K Quarterly results
06/18/2019 8-K Quarterly results
06/11/2012 8-K/A Form 8-K - Current report [amend]
05/08/2012 8-K/A Resignation/termination of a director, Appointed a new director
Docs: "EXHIBIT 2.1 SHARE PURCHASE AGREEMENT"
04/05/2012 8-K/A Form 8-K - Current report [amend]
02/24/2012 8-K/A Form 8-K - Current report [amend]
01/11/2012 8-K/A Appointed a new director
Docs: "EXHIBIT 3.1 CERTIFICATE FOR RENEWAL AND REVIVAL OF CHARTER",
"Patent License Agreement by and between Cronos Therapeutics Limited and Imperial College Innovations Limited",
"Amended Patent License Agreement by and between Cronos Therapeutics Limited and Imperial College Innovations Limited",
"Extension Letter Agreement by and between Cronos Therapeutics Limited and Imperial College Innovations Limited",
"Patent License Agreement by and between ValiRX PLC and Chroma Therapeutics Limited",
"Contract Repayable Grant Advance on the Diagnosis of Colorectal Cancer by “NucleosomicsTM” by and between ValiBio SA and The Walloon Region",
"Non-Exploitation and Third Party Patent License Agreement by and among ValiBio SA, ValiRX PLC and The Walloon Region",
"Agreement by and between Singapore Volition and PB Commodities Pte Limited",
"Share Purchase Agreement by and between Singapore Volition and ValiRX PLC",
"Deed of Novation by and among Singapore Volition Pte Limited, ValiRX PLC, ValiBio SA and Chroma Therapeutics Limited"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy